|
|
41
|
2791D
|
OVESTIN 1MG VAG CR (ASG) ESTRIOL
|
15G
|
A
|
41.9981
|
1MG
|
1
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
2791D
|
OVESTIN 1MG VAG CR (ASG) ESTRIOL
|
15G
|
A
|
45.80
|
1MG
|
1
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
41
|
27921
|
OVESTIN 0.5MG OV (ASG) ESTRIOL
|
15'S
|
A
|
41.9981
|
0.5MG
|
1
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
27921
|
OVESTIN 0.5MG OV (ASG) ESTRIOL
|
15'S
|
A
|
3.05
|
0.5MG
|
15
|
2026-04-01
|
|
No
|
No
|
Amend Protocol Quantity
|
6
|
|
|
40
|
2831AG
|
AMARYL 2MG TAB (SFA/COL) GLIMEPIRIDE
|
15'S
|
C
|
0.18
|
2MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
2831AG
|
AMARYL 2MG TAB (SFA) GLIMEPIRIDE (C)
|
15'S
|
C
|
0.2718
|
2MG
|
45
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
40
|
2831FJ
|
DAONIL 5MG TAB (SFA/COL) GLIBENCLAMIDE
|
100'S
|
A
|
0.11
|
5MG
|
120
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|
|
|
40
|
2831GP
|
GLIMEPIRIDE 2MG TAB (DRL/AHI)
|
100'S
|
C
|
0.13
|
2MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
2831GT
|
GLITISOL 5MG TAB (REM) GLIBENCLAMIDE
|
40'S
|
A
|
0.0537
|
5MG
|
120
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
2831GV
|
GETRYL 2MG TAB (GET) GLIMEPIRIDE
|
20'S
|
C
|
0.05
|
2MG
|
45
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
42
|
2831HD
|
GLIFORD 5MG TAB (JLP) GLIBENCLAMIDE
|
200'S
|
A
|
0.05
|
5MG
|
120
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
40
|
28321
|
DIAMICRON MR 60MG TAB (SER/STO) GLICLAZIDE
|
30'S
|
A
|
0.24
|
60MG
|
60
|
2022-04-01
|
2024-03-31
|
|
|
contract extended
|
6
|
|
|
40
|
2832AT
|
DIAMICROM MR 60MG TAB (SER/COL) GLICLAZIDE
|
30'S
|
A
|
0.24
|
60MG
|
60
|
2022-04-01
|
2024-03-31
|
|
|
Contract Extended
|
6
|
|
|
40
|
2832BA
|
AMARYL 4MG TAB (SFA/COL) GLIMEPIRIDE
|
15'S
|
C
|
0.27
|
4MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
2832BA
|
AMARYL 4MG TAB (SFA) GLIMEPIRIDE (C)
|
15'S
|
C
|
0.2718
|
4MG
|
60
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
40
|
2832BP
|
GLICLAZIDE MR 60MG TAB (SER/COL)
|
30'S
|
A
|
0.24
|
60MG
|
60
|
2022-04-01
|
2024-03-31
|
|
|
Name Change
|
6
|
|
|
40
|
2832BP
|
GLICLAZIDE MR 60MG TAB (SER/COL)
|
30'S
|
A
|
0.24
|
60MG
|
60
|
2022-04-01
|
2024-03-31
|
|
|
Name Change
|
6
|
|
|
41
|
2832BP
|
GLICLAZIDE MR 60MG TAB (SER)
|
30'S
|
A
|
0.2465
|
60MG
|
60
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
2832BP
|
GLICLAZIDE MR 60MG TAB (SER)
|
30'S
|
A
|
0.25
|
60MG
|
60
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
41
|
2832BQ
|
GLICLAZIDE MR 60MG TAB (SER)
|
30'S
|
A
|
0.2465
|
60MG
|
60
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|